Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Asset Utilization Ratio: 2017-2024

Historic Asset Utilization Ratio for Akebia Therapeutics (AKBA) over the last 8 years, with Dec 2024 value amounting to 0.69.

  • Akebia Therapeutics' Asset Utilization Ratio rose 1019.12% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year increase of 1019.12%. This contributed to the annual value of 0.69 for FY2024, which is 1970.81% up from last year.
  • Akebia Therapeutics' Asset Utilization Ratio amounted to 0.69 in FY2024, which was up 1,970.81% from 0.03 recorded in FY2023.
  • In the past 5 years, Akebia Therapeutics' Asset Utilization Ratio registered a high of 0.69 during FY2024, and its lowest value of 0.03 during FY2023.
  • For the 3-year period, Akebia Therapeutics' Asset Utilization Ratio averaged around 0.46, with its median value being 0.66 (2022).
  • As far as peak fluctuations go, Akebia Therapeutics' Asset Utilization Ratio skyrocketed by 3,580.06% in 2020, and later slumped by 94.94% in 2023.
  • Yearly analysis of 5 years shows Akebia Therapeutics' Asset Utilization Ratio stood at 0.42 in 2020, then decreased by 13.36% to 0.36 in 2021, then surged by 83.16% to 0.66 in 2022, then slumped by 94.94% to 0.03 in 2023, then surged by 1,970.81% to 0.69 in 2024.